发明名称 METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE
摘要 PROBLEM TO BE SOLVED: To provide pharmaceutical compositions containing dihydroergotamine (DHE) and methods in which DHE is administered to patients for treatment of migraine without side effects or adverse effects.SOLUTION: Methods for rapid treatment of migraine with DHE are disclosed comprising: dampening the peak plasma concentration (Cmax) and slightly delaying the peak such as to avoid activating the dopaminergic and adrenergic receptors, while achieving sufficient active binding to serotonin receptors to provide relief from migraine symptoms within a timeframe that permits rapid resolution of migraine symptoms. Inhaler devices suitable for the methods are disclosed. Kits for practicing the methods are disclosed.
申请公布号 JP2013224331(A) 申请公布日期 2013.10.31
申请号 JP20130162032 申请日期 2013.08.05
申请人 MAP PHARMACEUTICALS INC 发明人 COOK ROBERT O;SHREWSBURY STEPHEN B;RAMADAN NABIH N;ARMER THOMAS A
分类号 A61K31/48;A61K9/12;A61K9/14;A61K9/72;A61K47/48;A61P29/00;A61P43/00 主分类号 A61K31/48
代理机构 代理人
主权项
地址